Gastric carcinoids: Does type of surgery or tumor affect survival?

被引:9
作者
Crown, Angelena [1 ]
Kennecke, Hagen [1 ]
Kozarek, Richard [1 ]
Lopez-Aguiar, Alexandra G. [2 ]
Dillhoff, Mary [3 ]
Beal, Eliza W. [3 ]
Poultsides, George A. [4 ]
Makris, Eleftherios [4 ]
Idrees, Kamran [5 ]
Smith, Paula Marincola [5 ]
Nathan, Hari [6 ]
Beems, Megan [6 ]
Abbott, Daniel [7 ]
Fisher, Alexander, V [7 ]
Fields, Ryan C. [8 ]
Davidson, Jesse [8 ]
Maithel, Shishir K. [2 ]
Rocha, Flavio G. [1 ]
机构
[1] Virginia Mason Med Ctr, Digest Dis Inst, Seattle, WA 98101 USA
[2] Emory Univ, Div Surg Oncol, Dept Surg, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Div Surg Oncol, Columbus, OH 43210 USA
[4] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA 94305 USA
[5] Vanderbilt Univ, Dept Surg, Med Ctr, Div Surg Oncol, Nashville, TN 37240 USA
[6] Univ Michigan, Dept Surg, Div Hepatopancreatobiliary & Adv Gastrointestinal, Ann Arbor, MI 48109 USA
[7] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA
[8] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
关键词
ZOLLINGER-ELLISON-SYNDROME; MANAGEMENT;
D O I
10.1016/j.amjsurg.2018.12.057
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Gastric carcinoids are rare neuroendocrine tumors of the gastrointestinal tract. They are typically managed according to their etiology. However, there is little known about the impact of surgical strategy on the long-term outcomes of these patients. Methods: All patients who underwent resection of gastric carcinoids at 8 institutions from 2000 to 2016 were analyzed retrospectively. Tumors were stratified according to subtype (I, II, III, IV) and resection type (local resection, LR or formal gastrectomy, FG). Clinicopathological parameters, recurrence-free (RFS) and overall survival (OS) were compared between groups. Results: Of 79 patients identified with gastric carcinoids, 34 had type I lesions associated with atrophic gastritis, 4 had type II lesions associated with a gastrinoma, 37 had type III sporadic lesions, and 4 had type IV poorly-differentiated lesions. The mean age of presentation was 56 years in predominantly Caucasian (77%) and female (63%) patients. Mean tumor size was 2.4 cm and multifocal tumors were found in 24 (30%) of patients with the majority occurring in those with type I tumors. Lymph node positive tumors were seen in 15 (19%) patients and 7 (8%) had M1 disease; both most often in type IV followed by type III tumors. R0 resection was achieved in 56 (71%) patients while 15 (19%) had R1 resections and 6 (8%) R2 resections. Patients with type I and III tumors were equally likely to have a LR (50% and 43% respectively) compared to FG while those with type II and IV all had FG with one exception. Type IV tumors had the poorest RFS and OS while Type II tumors had the most favorable RFS and OS (p < 0.04 and p < 0.0004, respectively). While there was no difference in RFS in those patients undergoing FG versus LR, OS was worse in the FG group (p < 0.017). This trend persisted when type II and type IV groups were excluded (p < 0.045). Conclusion: Gastric carcinoid treatment should be tailored to tumor type, as biologic behavior rather than resection technique is the more important factor contributing to long-term outcomes. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 26 条
[1]  
Basuroy R, REV ARTICLE INVESTIG
[2]   Serum gastrin in Zollinger-Ellison Syndrome - II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and Comparison with 537 cases from hte literature. Evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features [J].
Berna, Marc J. ;
Hoffmann, K. Martin ;
Long, Scott H. ;
Serrano, Jose ;
Gibril, Fathia ;
Jensen, Robert T. .
MEDICINE, 2006, 85 (06) :331-364
[3]  
BORDI C, 1991, CANCER-AM CANCER SOC, V67, P663, DOI 10.1002/1097-0142(19910201)67:3<663::AID-CNCR2820670323>3.0.CO
[4]  
2-L
[5]   Review article: pathogenesis and management of gastric carcinoid tumours [J].
Burkitt, M. D. ;
Pritchard, D. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (09) :1305-1320
[6]   Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease [J].
Callahan, Ann F. ;
White, Michael ;
Ituarte, Philip ;
Gagandeep, Singh ;
Woo, Yanghee ;
Fong, Yuman ;
Melstrom, Laleh .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (09) :882-887
[7]   THE SYNDROME OF GASTRIC ARGYROPHIL CARCINOID-TUMORS AND NONANTRAL GASTRIC ATROPHY [J].
CARNEY, JA ;
GO, VLW ;
FAIRBANKS, VF ;
MOORE, SB ;
ALPORT, EC ;
NORA, FE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) :761-766
[8]   Gastric Neuroendocrine Tumours [J].
Crosby, David A. ;
Donohoe, Claire L. ;
Fitzgerald, Louise ;
Muldoon, Cian ;
Hayes, Brian ;
O'Toole, Dermot ;
Reynolds, John V. .
DIGESTIVE SURGERY, 2012, 29 (04) :331-348
[9]   Defining Surgical Indications for Type I Gastric Carcinoid Tumor [J].
Gladdy, Rebecca A. ;
Strong, Vivian E. ;
Coit, Daniel ;
Allen, Peter J. ;
Gerdes, Hans ;
Shia, Jinru ;
Klimstra, David S. ;
Brennan, Murray F. ;
Tang, Laura H. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (11) :3154-3160
[10]   Gastric Carcinoids [J].
Grozinsky-Glasberg, Simona ;
Alexandraki, Krystallenia, I ;
Angelousi, Anna ;
Chatzellis, Eleftherios ;
Sougioultzis, Stavros ;
Kaltsas, Gregory .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) :645-+